Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease/Experiment 3
From BugSigDB
Reviewed Marked as Reviewed by Claregrieve1 on 2023-4-16
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Crohn's disease Colitis, Granulomatous,CROHN DIS,Crohn Disease,Crohn disease,Crohn's associated gastritis,Crohn's disease,Crohn's disease of colon,Crohn's disease of large bowel,CROHNS DIS,Crohns Disease,Enteritis, Granulomatous,Enteritis, Regional,Gastritis Associated with Crohn Disease,Gastritis Associated with Crohn's Disease,granulomatous colitis,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,pediatric Crohn's disease,regional enteritis,crohn disease,crohn's disease
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Patients with ulcerative colitis
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Patients with Crohn's disease
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Crohn's disease
- Group 0 sample size Number of subjects in the control (unexposed) group
- 14
- Group 1 sample size Number of subjects in the case (exposed) group
- 15
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 3 months
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Statistical test
- Kruskall-Wallis
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Signature 1
Reviewed Marked as Reviewed by Claregrieve1 on 2023-4-16
Source: Table 2
Description: Differential abundance between patients with ulcerative colitis vs Crohn's disease
Abundance in Group 1: increased abundance in Patients with Crohn's disease
| NCBI | Quality Control | Links |
|---|---|---|
| Abiotrophia defectiva | ||
| Desulfovibrio | ||
| Pseudoramibacter | ||
| Slackia |
Revision editor(s): Claregrieve1, Suwaiba, Merit
Signature 2
Reviewed Marked as Reviewed by Claregrieve1 on 2023-4-16
Source: Table 2
Description: Differential abundance between patients with ulcerative colitis vs Crohn's disease
Abundance in Group 1: decreased abundance in Patients with Crohn's disease
| NCBI | Quality Control | Links |
|---|---|---|
| Butyricicoccus | ||
| Moryella | ||
| Staphylococcus | ||
| Capnocytophaga | ||
| Haemophilus | ||
| Janthinobacterium | ||
| Cardiobacterium | ||
| Lautropia | ||
| Propioniferax innocua | ||
| Shewanella | ||
| Corynebacterium |
Revision editor(s): Claregrieve1
